Biochemical effects of acute and subacute treatments with ambrein were investigated in rats by measuring the total proteins, cholesterol, triglycerides, GOT, GPT and alkaline phosphatase in the blood plasma. Also, determinations of prothrombin time (PT), partial thrombin time (PTT), thrombin time (TT) and fibrinogen level were performed. Furthermore, changes in plasma electrolyte concentration were studied. Ambrein administered i.p. did not cause any toxic symptoms in the liver as revealed by the histology of the liver tissue both in acute and subacute treatments. Ambrein itself did not significantly affect the plasma protein, cholesterol, GOT and GPT profiles, but lowered alkaline phosphatase at high doses (50 and 250 mg/kg) after subacute treatment. Thus far, no specific pattern of action of ambrein in electrolyte control has been found. However, it increased PT, PTT and TT and decreased fibrinogen levels in both the acute and subacute studies, pointing towards its potential as an anticoagulant and antifibrinogenic agent.
Ambrein is a major constituent of ambergris, an internal secretion of the sperm blue whale (Physeter catodon) (1) . Ambergris constitutes mainly of 55-857o ambrein, epicoprosteral and a number of odorless non-volatile oils (2) . Many reports are available on the folklore importance of ambergris, the crude organic substance, on account of some excellent medicinal properties it possesses. In the eastern discipline of medicine, compounds and pastes in which organic ambergris is used are thought to be an excellent remedy for nervous disorders (3 -5) . A primary screening profile regarding the cholinergic and/or adrenergic effects of some fractions of ambergris has been reported earlier (6) , and a few reports regarding the effects of ambrein on the cardiovascular system (7) blood glucose level (8) , edema (9) and mode of action in antinociception (10) have been published from the same laboratory. However, no paper has been published that has explored the biochemical and hematological effects of this substance. Therefore, the present study was designed to investigate the effects of acute and chronic treatment with respect to the biochemical and hematological changes induced by ambrein and how they are related to its folklore importance.
MATERIALS AND METHODS

Drugs and animals
The ambergris was purchased from a local market in Riyadh, Saudi Arabia. Isolation, identification and purification of ambrein from ambergris was done by the method described previously (6) . Extra light olive oil was purchased from market, and the drug was dissolved in it by gentle heat. Kits for analysis were purchased from Boehringer Mannheim GmbH, Mannheim, Germany. Male Wistar albino rats (bred at The Experimental Animal Care Centre, King Saud University, Riyadh), all roughly of the same age (7-to 8-weeks-old) and weighing 180-200 g, were used in this study. All the animals were maintained under controlled conditions of temperature, humidity and light and were provided with Purina chow and water ad libitum except on the day of sacrifice.
Acute treatment
Preliminary experiment revealed that i.p. injection of vehicle had no significant effect on blood plasma contents when compared to the untreated control group. The dose of ambrein used in this study (250 mg/kg) was reported earlier to be pharmacologically active (9, 10) .
The animals were randomly assigned to the control and treatment groups, seven animals in each group. Groups 1, 2, 3 and 4 were intraperitoneally given ambrein at a dose of 250 mg/kg dissolved in olive oil. Each group had its own control group (consisting of seven animals each) injected with 1 ml/kg of olive oil. At the time of sacrifice (3, 6, 12 and 24 hr post treatment), the animals were killed by cervical dislocation, and blood was taken by cardiac puncture. The blood samples from each animal were collected in two different vials. Each 3-ml aliquot of blood was taken into a heparinized vial and centrifuged. Plasma was isolated and refrigerated at -201C until used for determinations of proteins, triglycerides, cholesterol, GOT, GPT, alkaline phosphatase and elemental analysis by atomic absorption spectrophotometry for Ca t+, Fe 2+, Mgz+, K+ and Na+ concentrations. Other 3ml aliquots of blood samples were taken into citrated blood sampling vials and immediately sent to the hospital for prothrombin time (PT), partial thrombin time (PTT), thrombin time (TT) and fibrinogen (0) level determinations by using a coagulometer (Biomatic Biosarstedt, Freiburg, Germany).
The liver tissue was excised and fixed in 10010 buffered formalin. Hematoxylin and eosin-stained sections (11) were examined under the microscope for histopathological changes in a blind manner.
Chronic treatment
The animals used were of the same batch, weight and age range as in the acute study. A total of 28 rats were randomly assigned to different control and treatment groups. The groups consisted of the following: group 1, control (olive oil 1 ml/kg, i.p.); groups 2, 3 and 4 were injected i.p. with ambrein, dissolved in olive oil at doses of 10, 50 and 250 mg/kg of body weight, respectively. Because it was noted that ambrein (10 mg/kg) had a persistant sig-nificant effect on blood glucose level in rats even after 24 hr (8), the i.p. injections were made every alternate day for five weeks. In each case, the animals were killed by cervical dislocation a day after the last injection. Blood and liver tissue samples were taken and processed as described for acute studies.
Statistical analyses
The different parameters were analyzed by Student's ttest.
RESULTS
Acute treatment
Treatment with ambrein at 250 mg/kg in groups 1, 2, 3 and 4 caused no significant changes in plasma contents of total cholesterol, triglycerides and GOT at 3, 6 and 12 hr post treatment, as compared to their respective controls (Table 1 ). However, there was a statistically significant decrease in triglycerides and GOT and an increase in total cholesterol 24 hr after treatment. Also, highly significant rises in total protein and alkaline phosphatase were observed throughout the period of the experiment, when compared to their respective control groups. The levels of GPT increased from 6 to 24 hr, but there was no significant change in GPT until 3 hr of treatment.
PT, PTT and TT ( Table 2 ) increased significantly at 3 and 6 hr when compared to those of the control groups. There was no significant increase in these times at 12 and 24 hr post administration of the drug except for a moderately significant increase in thrombin time at 24 hr. The effect of the drug on fibrinogen was more pronounced after 6 hr and less significant at 12 hr, indicating the antifibrinogenic effects of ambrein.
Treatment with ambrein did not show any comparable effect on calcium ions (Table 3 ) after 3, 6 and 24 hr except at 12 hr when it was slightly higher than that of the control group. However, other ionic concentrations were affected significantly. The concentration of Fe 2+ and K+ significantly increased throughout the experiment except at 6 hr when the rise in K+ was not significant in comparison with group 1. Of course, hyponatremia was highly significant at all the intervals throughout the study. Histological examination of the liver tissue did not show any pathological symptoms after acute treatment. Tables 4, 5 and 6 show effects of treatment with ambrein at 10, 50 and 250 mg/kg for five weeks on the plasma contents of rats; with a dose of 50 mg/kg, the triglycerides increased significantly, and at a dose of 250 mg/kg, the activity level of alkaline phosphatase decreased significantly from 63.5 to 42.3 U/1. Plasma proteins, cholesterol, GOT and GPT did not change appreciably with any of the doses studied (Table 4) .
Studies on chronic treatment
Ambrein treatment was found to cause a significant in-crease in prothrombin time at doses of 10 and 250 mg/kg and a highly significant rise at 50 mg/kg. Also, thrombin time showed marked increases at all the tested doses. Ambrein reduced the amount of fibrinogen significantly in a dose-dependent manner, but without any appreciable changes in partial thrombin time at all the tested doses (Table 5) .
Treatment with ambrein at 10 mg/kg caused a mild reduction in Fe 2+ and a highly significant reduction in Na+ when compared to group 1 ( Table 6 ). The treatment with 50 mg/kg increased the Ca 21 concentration and decreased Fe 2+. Ambrein at 250 mg/kg did not cause any noticeable change in concentrations of electrolytes except for K+, which was extensively decreased.
None of the parameters evaluated for histopathology at any dose tested gave any important findings to be reported.
DISCUSSION
Under acute experimental conditions, ambrein seems to be effective at 3 and 6 hr post administration, causing highly significant elevation in prothrombin, partial thrombin and thrombin times. However, a highly significant decrease in fibrinogen level was observed at 6 hr which recovered to the normal level at 24 hr when compared to their respective controls. Similarly, after chronic treatment, increases in PT and TT were observed at any dose tested, and there was a dose-dependent significant decrease in fibrinogen. Prothrombin is converted to thrombin in the clotting process. The sequence of reactions involved in this process requires Ca 21, thromboplastin, the Stuart-Prower factor, a labile factor and a stable factor. Deficiencies in any of the components result in a prolonged prothrombin time (12) . Fibrinogen changes into fibrin by the action of thrombin. Therefore a prolongation of thrombin time reflects the effects of ambrein on fibrinogen. Hypofibrinogenemia is generally caused not by deficient production but by increased con-sumption or breakdown by the action of fibrinolytic enzymes (12) . Several reports suggested that terpenes possess the ability to stabilize lysosomal membranes and cause significant anti-coagulant and anti-fibrinogenic effects (13) . Most likely, this effect of ambrein is attributable to its terpene structure.
Ambrein treatment is found to elevate testosterone levels in plasma (S.A. Taha, unpublished data). In the present study, after acute treatment with ambrein, a highly significant hyperproteinemia was observed at 3, 6 and 12 hr and a moderately significant increase seen at 24 hr. Androgens and growth hormones are reported to increase protein synthesis and serum protein levels (12, 14) . However, there is no significant change in protein level in chronic treatment. This discrepancy might be due to the hormonal balance achieved during the chronic treatment. The activity profile of ambrein in the time course study showed a markedly significant rise in alkaline phos-phatase, while in chronic studies, only the highest dose decreased its activity. Certainly, we can not exclude the possibility that this discrepancy is related to its distribution, presence in tissue and activity in blood plasma. Since this enzyme is widely distributed in tissues and muscles so a rise in its activity might be attributed to some scars, abdominal masses or muscle damage due to injection (15, 16) . After the chronic treatment, the aminotransferases GOT and GPT showed no significant change at any of the tested doses compared to the control group. The liver is a rich source of aminotransferases, and the serum level of both these aminotransferases usually rise and fall together indicating hepatic damages (17) . Our results are further in agreement with the histology of liver tissue that revealed no liver damage, consistent with no significant change in these enzymes.
A slight increase in serum Ca" is attributable to the overall increase of total proteins in time course studies at 12 hr. It is known that protein bound non-diffusible calcium constitutes 40-50% of the total serum calcium (12) , and hypercalcemia due to hyperproteinemia is generally associated with normal ionized calcium values (18) . The increase in Fe2+ in acute treatment is also related to the increase in proteins or an increase in the iron binding protein fraction. Little is known about the factors regulating Mg 21 levels in the plasma. It is believed, however, that parathyroid hormones (parathyrin) and aldosteron play a role, and the latter is known to regulate the excretion of Mg 21 in a way similar to K+. As it has been suggested in a previous report (19) , ambrein probably exerts its analgesic activity by preventing synthesis and/or release of prostaglandins. So this inhibition of prostaglandins may involve a decrease in glomerular filtration rate, an increase in medullary solute concentration (14) and loss of sodium. Hyperkalemia was seen in the time course studies. Also, a significant decrease of Na+ may cause renal acidosis that interferes with Na+, H+ exchange and thus may result in retention of K+ in the serum (12) .
From our present data, it appears likely that ambrein is devoid of any serious adverse effects on biochemical contents of the plasma including proteins, cholesterol, triglycerides and aminotransferases.
However, abmrein was found to be a potent anticoagulant and antifibrinogenic agent. Further studies are warranted to explore its mode of action to determine its safety for medicinal use and to provide support for its folklore claims.
